MoneyWorks4Me

Revenue reduced marginally to stand at Rs. 13071.20 millions during the quarter ended March 2023. The figure stood at Rs. 13176.70 millions during the year-ago period.The Total revenue for the quarter ended March 2023 of  Rs. 1305.40  millions  grew by 214.40% from Rs. 415.20 millions.The company reported a degrowth in operating Profit to 1711.40 millions from 1777.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 13071.20 13176.70 -0.80 51490.00 50354.10 2.26 51490.00 50354.10 2.26
Other Income 19.60 117.80 -83.36 35.40 511.40 -93.08 35.40 511.40 -93.08
PBIDT 1711.40 1777.60 -3.72 6678.80 9599.50 -30.43 6678.80 9599.50 -30.43
Interest 135.90 60.10 126.12 490.00 170.20 187.90 490.00 170.20 187.90
PBDT 1575.50 1717.50 -8.27 6188.80 9429.30 -34.37 6188.80 9429.30 -34.37
Depreciation 735.40 1221.00 -39.77 2729.50 2849.20 -4.20 2729.50 2849.20 -4.20
PBT 840.10 496.50 69.20 3459.30 6580.10 -47.43 3459.30 6580.10 -47.43
TAX -465.30 81.30 -672.32 -8.00 1144.60 -100.70 -8.00 1144.60 -100.70
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 1305.40 415.20 214.40 3467.30 5435.50 -36.21 3467.30 5435.50 -36.21
Equity 393.10 393.10 0.00 393.10 393.10 0.00 393.10 393.10 0.00
PBIDTM(%) 13.09 13.49 -2.95 12.97 19.06 -31.96 12.97 19.06 -31.96

Alembic Pharma Share Price

823.85 20.30 (2.53%)
26-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1901.00
Dr. Reddys Labs. 1186.40
Cipla 1408.40
Lupin 2191.20
Zydus Lifesciences 1147.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: